Although many medical schools are now offering genomic sequencing to patients with rare diseases, insurance reimbursement is still doubtful. The Medical College of Wisconsin has sequenced over 36 whole genome and 400 whole exomes. Baylor College of Medicine has sequenced 3,500 exomes and reported that of 250 cases of whole-exome sequencing, the genetic cause of […]

To address climate change, the EPA has proposed guidelines for states in developing plans to reduce greenhouse gas (GHG) emissions from fossil-fueled electric-generating units (EGUs). The guidelines are based on state-specific rate-based goals for carbon dioxide emissions from power plants. Carbon dioxide accounts for 82% of US GHG emissions. The rule is designed to reduce […]

Genetic testing is becoming standard at cancer hospitals in order to advance drug trials and treatment. In the latest example, Quest Diagnostics and Sloan Kettering are partnering to screen patients, aiming to test for 341 genes in 2015. Although the test will cost $4,000, patients will not pay the full amount. Sloan Kettering intends to […]

In late 2013, the Tufts Center for the Study of Drug Development studied personalized medicines in the stages beyond Phase II trials. The information used was compiled from commercial databases, public sources and the Center’s own database. Out of 580 identified products, 66 were likely to be marketed as personalized medicines on approval, although a […]